# PACT Pharma: Biotechnology, South San Francisco, United States

> PACT Pharma: PACT Pharma is a clinical-stage biopharmaceutical company based in South San Francisco, California, founded in 2016.

Source: https://millionrounds.com/startup/pact-pharma (Millionrounds; every figure on the page links to its filing or article)

United States · [Biotechnology startup](https://millionrounds.com/companies)

# PACT Pharma

PACT Pharma is a clinical-stage biopharmaceutical company based in South San Francisco, California, founded in 2016.

Funding reported Last round: Series C

Biotechnology South San Francisco, United States

Company summary

- **Founded:** 2016 10 years old
- **Team:** 18 11 to 50 people
- **Funding reported:** $200M in dollars
- **Last round:** Series C Jan 2020

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for PACT Pharma has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About PACT Pharma

PACT Pharma is a clinical-stage biopharmaceutical company based in South San Francisco, California, founded in 2016.

The company focuses on developing personalized cancer therapies, specifically through its Personalized Adoptive Cell Therapy (PACT) approach. PACT Pharma specializes in creating individualized immunotherapies that utilize the patient's immune system to target solid tumors, which have historically been challenging to treat. The company employs a proprietary technology platform that includes neoantigen identification, personalized T-cell receptor (TCR) engineering, and non-viral delivery methods. Its lead product, NeoTCR-P1, is a fully personalized TCR-T cell therapy designed to treat solid tumors by reprogramming the immune system to recognize and attack cancer cells. PACT Pharma's vision emphasizes making personalized treatment accessible to all cancer patients, regardless of their background.

## What company datasets say PACT Pharma raised

Funding, as reported

Reported in all **$200M** in dollars

Rounds **3**

Last round **Series C**

Last round size **$75M**

Last round date **Jan 2020**

Investors listed **15**

## The company, in detail

What they build

Known for

cell therapy pharma tcr b2b cancer

Built with from their website

GitHub Actions Azure Devops Docker Google App Engine Amazon Elastic Container Registry Atlassian Google Cloud Google Cloud Run AWS Lambda Apple Business Manager

+8 more

Google Cloud Hosting Microsoft Exchange Microsoft Azure Microsoft 365 Apps & Services Jenkins Google Sites AWS Fargate DocuSign

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, 325414, SIC 2836
- **Region:** California
- **Revenue:** $8.0M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/pact-pharma)

## Biotechnology in United States

Startups like it

- [**National Resilience** founded 2020 *Raised*](https://millionrounds.com/company/national-resilience)
- [**CREATE Medicines** Cambridge · founded 2019 *Raised*](https://millionrounds.com/company/create-medicines)
- [**AusperBio Therapeutics** Startup *Raised*](https://millionrounds.com/company/ausperbio-therapeutics)
- [**City Therapeutics** Startup *Raised*](https://millionrounds.com/company/city-therapeutics)
- [**Nohla Therapeutics** Seattle · founded 2015 *Raised*](https://millionrounds.com/company/nohla-therapeutics)
- [**Genapsys** Redwood City · founded 2010 *Raised*](https://millionrounds.com/company/genapsys)
- [**Proxima Bio** Startup *Raised*](https://millionrounds.com/company/proxima-bio)
- [**Infinimmune** Alameda · founded 2022 *Raised*](https://millionrounds.com/company/infinimmune)

## Is this your company?

Add your raise, your deck and your story, and put PACT Pharma in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)
